Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. - Wikidata - awgldk - TriplyDB

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

http://www.wikidata.org/entity/Q30370903

about

Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis Ears of the Armadillo: Global Health Research and Neglected Diseases in Texas Influence of diabetes mellitus on the immunity to human tuberculosis.Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases.Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia.Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012 Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications.Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity Type 2 diabetes and multidrug-resistant tuberculosis The impact of diabetes on tuberculosis treatment outcomes: a systematic review.Tuberculosis and diabetes mellitus: convergence of two epidemics.Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico Diabetes and immunity to tuberculosis.Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs.Tuberculosis and diabetes mellitus - an underappreciated association.Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis Impact of diabetes and smoking on mortality in tuberculosis.Impact of diabetes on the natural history of tuberculosis.The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes.Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases.Type 2 diabetes: an independent risk factor for tuberculosis: a nationwide population-based study.Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia.The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in South India Diabetes: A Contributor to Tuberculosis in Tropical Australia Clinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters.Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes.Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus.

P2860

Q24648013-A67277E5-A770-49AE-AC0F-B148878E0F61 Q28383076-4CBFD43B-033E-4AE7-8775-A69E5FA7CD8A Q28545145-EC485822-4D46-4C01-9389-EB9D76A5FB13 Q28681061-A8B27AE3-B2CD-4D85-98E9-EC87251AB8C6 Q30234363-2A7AA90D-9CE6-4D74-AB0E-ECF1FB0B06F1 Q30234697-E32A08FA-D77F-4514-95CD-996FCEB32DEE Q30355645-E6A37B01-4D12-45F7-939A-2F1A3BA82DF2 Q30357517-2EC0D639-388F-4DB4-BDE4-37B4E78D6C15 Q30383012-431313B5-A055-4F0C-9C68-3A02F4856512 Q30494609-B523B12E-5FC1-420B-B0D5-1D68B97BA3BA Q30601364-691506A1-1ED1-4809-8CFA-A7315C103AA2 Q33573674-646D49C2-5EF5-4411-81F9-A1600C5194B8 Q33639211-BED930AB-5B5F-4157-B6B8-16650192284F Q33700655-E97D452F-C26C-4FD3-ADB7-D8B4BA56FA08 Q33702620-CA716DF2-4CF5-4426-BD23-498C6977F90A Q33920693-9CC9643D-8D68-4B4A-948E-F358A8404D0E Q33948702-8F122819-3E55-490B-AE8E-054392898B3E Q34156234-4AFFAAA4-3F39-4577-A2D7-A5135CD73CD5 Q34206649-5BA005BA-F261-43DB-B68E-EF68E99AA8F3 Q34424824-1C63610E-E2CB-484C-B854-9A37D7543E4A Q34430226-67694C3C-C142-4B9B-BDB1-9874509466B1 Q34442201-EF1B912D-837A-4045-B38F-DCFBF30454CE Q34466787-78217FB4-44DE-48BC-A60A-8DAFDF9009DB Q34505943-0A25B87A-3419-43E5-921D-549D11508235 Q34612807-614BC4FA-0AA0-472A-AF9F-6D866412F93A Q34663669-A6F3249E-443A-4B00-A1CF-497EF437F983 Q34891783-6285586F-4CB5-409D-A7AD-9F819E82C829 Q34946090-F0580AF7-AB6B-471F-80F1-E3750B645B05 Q35043634-C56FCFAD-2DAA-464F-AF00-950DD81EE1CE Q35132249-16DDF2F8-BC1C-4E9E-9996-B42D7405C192 Q35558240-1798C603-DCB0-48C0-8F02-B95E667B95E7 Q35663649-15CF298D-DA07-4E82-A86B-D85EB844A427 Q35719595-D876EDB5-2C13-4050-B549-4B712EB8965A Q36026279-F78043B7-033E-44D8-89CB-4EEAD105FF74 Q36290609-F00B55CB-0282-491B-8350-D1A8037852F1 Q36338729-9A8CD84D-9205-4817-9641-2BFB08BF4049 Q36453623-FC6E491F-F832-47D2-919F-21F689E60238 Q36562830-1B065F71-2CFA-439E-A3D1-2440629A5D27 Q36648076-544E96ED-5006-402A-B3BA-3E87472E0617 Q37070363-72DEDB1E-E8FD-45CE-ABF0-E901D01C79B8

P2860

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

http://www.wikidata.org/entity/Q30370903

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Tuberculosis in poorly control ...... peripheral white blood cells.

@ast

Tuberculosis in poorly control ...... peripheral white blood cells.

@en

type

label

Tuberculosis in poorly control ...... peripheral white blood cells.

@ast

Tuberculosis in poorly control ...... peripheral white blood cells.

@en

prefLabel

Tuberculosis in poorly control ...... peripheral white blood cells.

@ast

Tuberculosis in poorly control ...... peripheral white blood cells.

@en

P1433

Q30370903-B03F7F04-95C5-403C-AC90-E95160A0DD7D

P1476

Q30370903-1D69E863-A9DF-400C-94C1-54B11788974D

P2093

Q30370903-0382181F-D6D6-4516-A7AB-2066F88D7C94

Q30370903-4965FB86-5EF8-490E-AA92-78C4D66239BC

Q30370903-7A372305-3840-446D-81E4-18D46C10D1D8

Q30370903-81330D73-6C1A-44F9-B1EC-3963494E5BF6

Q30370903-850852B8-1774-4377-9552-08AD3A8F78CE

Q30370903-D28F1FC2-27E0-4C9A-9962-3913C0B8590E

Q30370903-D785586E-8F21-4B9F-A3CA-4288844DFF74

P2860

Q30370903-0605778F-1A3B-461C-9BB8-994B75B8385E

Q30370903-0817236A-BB96-46B7-B22A-569CF9B244EF

Q30370903-15A9380C-31EC-4773-8757-5A66ABA2B85E

Q30370903-1FE599D2-B95F-4567-AD6C-3276A248A6D2

Q30370903-28EA3754-B61C-426A-B9F8-17BE1D123271

Q30370903-3C68A8BA-959C-42E3-9DED-3E18C8A82976

Q30370903-3E4BB24D-5051-4556-B46B-FC12611FBE1E

Q30370903-4C5C8098-DF4E-4E63-B9EF-DD362EA0460F

Q30370903-59EC852C-FC2D-472E-B201-DA6708B76D29

Q30370903-66D11076-8362-4305-9E8B-BB0455FB158A

P304

Q30370903-2E791457-7BB9-49C4-A02E-09C29300C4E1

P31

Q30370903-07779099-D56F-4163-9E6C-BDBBE571AF40

P356

Q30370903-2BAE8192-AC05-42B2-BF0E-399B4F3D92D0

P407

Q30370903-3F0D0965-76B1-4AC1-ADE9-C309E0C7F848

P433

Q30370903-7483B98D-6417-4A63-B20B-A3B83EC4727E

P478

Q30370903-0E5D3D4E-011D-4061-8F28-631DBB771C09

P50

Q30370903-DC1C8A95-902D-4307-A7FD-0D97423D61E7

P577

Q30370903-7891148E-05A5-43F7-9910-6B55DEA573EF

P5875

Q30370903-F4C41D0B-9AE6-4E59-B8AA-DD6B5C613691

P698

Q30370903-61C0D4DC-9F7D-4C8D-93F9-A79DC20D7BA3

P921

Q30370903-4ADE9A6F-F175-47BB-9DBE-EDF23508DC2D

Q30370903-97A5DC82-6B40-4D32-811B-433CE612A971

Q30370903-B2F66F84-2CDB-41B4-8462-343A57749511

P932

Q30370903-1F19EEB0-873E-49DF-AFE3-CF997AD025F5

P356

P1433

Clinical Infectious Diseases

P1476

Tuberculosis in poorly control ...... peripheral white blood cells.

@en

P2093

Adrian Salinas

http://www.w3.org/2001/XMLSchema#string

Blanca I Restrepo

http://www.w3.org/2001/XMLSchema#string

Francisco Mora

http://www.w3.org/2001/XMLSchema#string

Mohammad H Rahbar

http://www.w3.org/2001/XMLSchema#string

Nicolas Cortes-Penfield

http://www.w3.org/2001/XMLSchema#string

Paula A Pino

http://www.w3.org/2001/XMLSchema#string

Susan P Fisher-Hoch

http://www.w3.org/2001/XMLSchema#string

P2860

Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances

Standards of medical care in diabetes--2006

Tuberculosis and diabetes in southern Mexico.

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

The emerging epidemic of obesity in developing countries.

Non-enzymatic glycation of IgG: an in vivo study.

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus.

Immune dysfunction in patients with diabetes mellitus (DM).

Negative regulation of cytokine signaling.

P304

634-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/590565

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Joseph B. McCormick

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51426017

http://www.w3.org/2001/XMLSchema#string

P698

18652554

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

type-2 diabetes

P932

2900313

http://www.w3.org/2001/XMLSchema#string